CircSpna2 attenuates cuproptosis by mediating ubiquitin ligase Keap1 to regulate the Nrf2-Atp7b signalling axis in depression after traumatic brain injury in a mouse model

Mengran Du , Jiayuanyuan Fu , Jie Zhang , Ziyu Zhu , Xuekang Huang , Weilin Tan , Lian Liu , Zhijian Huang , Xin Liu , Qiuhao Tan , ZhengBu Liao , Yuan Cheng

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (11) : e70100

PDF
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (11) :e70100 DOI: 10.1002/ctm2.70100
RESEARCH ARTICLE
CircSpna2 attenuates cuproptosis by mediating ubiquitin ligase Keap1 to regulate the Nrf2-Atp7b signalling axis in depression after traumatic brain injury in a mouse model
Author information +
History +
PDF

Abstract

This study explores the role of circSpna2 in depression following traumatic brain injury (TBI). It was found that circSpna2 is significantly downregulated in TBI patients, and its expression levels correlate with depressive symptoms. In TBI mouse models, overexpression of circSpna2 alleviated depression-like behaviours, while its knockdown exacerbated these symptoms, suggesting its potential as both a biomarker and a therapeutic target for post-TBI depression. Mechanistically, circSpna2 regulates the Nrf2-Atp7b signalling pathway by binding to the DGR domain of Keap1, which prevents Nrf2 ubiquitination and enhances Nrf2 activity. This in turn promotes the transcription of Atp7b, a copper transport protein, helping to maintain copper homeostasis and mitigate copper-induced oxidative stress, a key protein of cell death (cuproptosis). The overexpression of circSpna2 also improved mitochondrial function and synaptic integrity, which are typically impaired by copper dysregulation. These findings highlight the therapeutic potential of circSpna2 in managing TBI-related depression through the regulation of oxidative stress and copper homeostasis.

Keywords

circRNAs / cuproptosis / depression / traumatic brain injury / ubiquitination

Cite this article

Download citation ▾
Mengran Du, Jiayuanyuan Fu, Jie Zhang, Ziyu Zhu, Xuekang Huang, Weilin Tan, Lian Liu, Zhijian Huang, Xin Liu, Qiuhao Tan, ZhengBu Liao, Yuan Cheng. CircSpna2 attenuates cuproptosis by mediating ubiquitin ligase Keap1 to regulate the Nrf2-Atp7b signalling axis in depression after traumatic brain injury in a mouse model. Clinical and Translational Medicine, 2024, 14(11): e70100 DOI:10.1002/ctm2.70100

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Juengst SB, Kumar RG, Wagner AK, Failla MD. Acute inflammatory biomarker profiles predict depression risk following moderate to severe traumatic brain injury. J Head Trauma Rehabil. 2015;30(3):207-218.

[2]

Fann JR, Burington B, Leonetti A, Jaffe K, Katon WJ, Thompson RS. Psychiatric illness following traumatic brain injury in an adult health maintenance organization population. Arch Gen Psychiatry. 2004;61:53-61.

[3]

Siddiqi SH, Kandala S, Hacker CD, et al. Precision functional MRI mapping reveals distinct connectivity patterns for depression associated with traumatic brain injury. Sci Transl Med. 2023;15:eabn0441.

[4]

Lim S-W, Shiue Y-L, Liao J-C, et al. Simvastatin therapy in the acute stage of traumatic brain injury attenuates brain trauma-induced depression-like behavior in rats by reducing neuroinflammation in the hippocampus. Neurocrit Care. 2017;26:122-132.

[5]

Chen Y-T, Nyam T-TE, Tsai L-C, et al. Pretreatment with lovastatin improves depression-like behavior after traumatic brain injury through activation of the AMPK pathway. World Neurosurg. 2023;180:e350-e363.

[6]

Tentu PM, Bazaz MR, Pasam T, et al. Oxyberberine an oxoderivative of berberine confers neuroprotective effects in controlled-cortical impact mouse model of traumatic brain injury. Int J Neurosci. 2023:1-16. Ahead of print.

[7]

Davila-Valencia I, Saad M, Olthoff G, et al. Sex specific effects of buprenorphine on adult hippocampal neurogenesis and behavioral outcomes during the acute phase after pediatric traumatic brain injury in mice. Neuropharmacology. 2024;245:109829.

[8]

Porter KE, Stein MB, Grau PP, et al. Impact of PTSD treatment on postconcussive symptoms in veterans: a comparison of sertraline, prolonged exposure, and their combination. J Psychiatr Res. 2024;173:64-70.

[9]

Scheiber IF, Dringen R. Astrocyte functions in the copper homeostasis of the brain. Neurochem Int. 2013;62(5):556-565.

[10]

Gaetke LM, Chow CK. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology. 2003;189(1-2):147-163.

[11]

Zhang H, Nagai J, Hao L, Jiang X. Identification of key genes and immunological features associated with copper metabolism in Parkinson’s disease by bioinformatics analysis. Mol Neurobiol. 2024;61(2):799-811.

[12]

Zhang Y, Zhou Q, Lu L, et al. Copper induces cognitive impairment in mice via modulation of cuproptosis and CREB signaling. Nutrients. 2023;15(4):972.

[13]

Squitti R, Polimanti R. Copper phenotype in Alzheimer’s disease: dissecting the pathway for the possible use of chelating agents. Pharmacol Res. 2013;76:41-47.

[14]

Desai V, Kaler SG. Role of copper in human neurological disorders. Am J Clin Nutr. 2008;88(3):855S-858S.

[15]

Scheiber I, Mercer JFB, Dringen R. Metabolism and functions of copper in brain. Prog Neurobiol. 2014;116:33-57.

[16]

Tsvetkov P, Coy S, Petrova B, Dreishpoon M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254-1261.

[17]

Li Z, Zhou H, Zhai X, et al. MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function. Cell Death Dis. 2023;14:733.

[18]

Guo Q, Ma M, Yu H, Han Y, Zhang D. Dexmedetomidine enables copper homeostasis in cerebral ischemia/reperfusion via ferredoxin 1. Ann Med. 2023;55:2209735.

[19]

Lei D, Sun J, Xia J, Cuproptosis-related genes prediction feature and immune microenvironment in major depressive disorder. Heliyon. 2023;9:e18497.

[20]

An Y, Li S, Huang X, Chen X, Shan H, Zhang M. The role of copper homeostasis in brain disease. Int J Mol Sci. 2022:23:13850.

[21]

Kohansal M, Alghanimi YK, Banoon SR, et al. CircRNA-associated ceRNA regulatory networks as emerging mechanisms governing the development and biophysiopathology of epilepsy. CNS Neurosci Ther. 2024;30(4):e14735.

[22]

Hui Y, Wenguang Y, Wei S, Haoran W, Shanglei N, Ju L. circSLC4A7 accelerates stemness and progression of gastric cancer by interacting with HSP90 to activate NOTCH1 signaling pathway. Cell Death Dis. 2023;14:452.

[23]

Zheng P, Shu L, Ren D, Kuang Z, Zhang Y, Wan J. circHtra1/miR-3960/GRB10 axis promotes neuronal loss and immune deficiency in traumatic brain injury. Oxid Med Cell Longev. 2022;2022:3522492.

[24]

Cheng Y-Q, Wu C-R, Du M-R, et al. CircLphn3 protects the blood-brain barrier in traumatic brain injury. Neural Regen Res. 2022;17:812-818.

[25]

Fu J, Zhou Q, Wu B, et al. Protective effects and regulatory pathways of melatonin in traumatic brain injury mice model: transcriptomics and bioinformatics analysis. Front Mol Neurosci. 2022;15:974060.

[26]

Wu C, Du M, Yu R, et al. A novel mechanism linking ferroptosis and endoplasmic reticulum stress via the circPtpn14/miR-351-5p/5-LOX signaling in melatonin-mediated treatment of traumatic brain injury. Free Radic Biol Med. 2022;178:271-294.

[27]

Zou Z-L, Ye Y, Zhou B, Zhang Y. Identification and characterization of noncoding RNAs-associated competing endogenous RNA networks in major depressive disorder. World J Psychiatry. 2023;13:36-49.

[28]

Yu X, Bai Y, Han B, et al. Extracellular vesicle-mediated delivery of circDYM alleviates CUS-induced depressive-like behaviours. J Extracell Vesicles. 2022;11:e12185.

[29]

Zhu J, Guo S, Hu S, Chen Q. The 2210408F21Rik/miR-1968-5p/Hras axis regulates synapse-related proteins in a mouse model of depressive-like behaviors through a ceRNA mechanism. Behav Brain Res. 2023;447:114440.

[30]

Juengst SB, Kumar RG, Wagner AK, Failla MD. Acute inflammatory biomarker profiles predict depression risk following moderate to severe traumatic brain injury. J Head Trauma Rehabil. 2015;30(3):207-218.

[31]

Bombardier CH, Fann JR, Temkin NR, Esselman PC, Barber J, Dikmen SS. Rates of major depressive disorder and clinical outcomes following traumatic brain injury. JAMA. 2010;303(19):1938-1945.

[32]

Doering S, Herpertz S, Hofmann T, et al. What kind of patients receive inpatient and day-hospital treatment in departments of psychosomatic medicine and psychotherapy in Germany. Psychother Psychosom. 2023;92:49-54.

[33]

Hynes TJ, Hrelja KM, Hathaway BA, et al. Dopamine neurons gate the intersection of cocaine use, decision making, and impulsivity. Addict Biol. 2021;26(6):e13022.

[34]

Jiang C, Yang X, He G, et al. CRHCeA→VTA inputs inhibit the positive ensembles to induce negative effect of opiate withdrawal. Mol Psychiatry. 2021;26(11):6170-6186.

[35]

Li R, Li Y, Kristiansen K, Wang J, SOAP: short oligonucleotide alignment program. Bioinformatics (Oxford, Engl). 2008;24:713-714.

[36]

Kim D, Langmead B, Salzberg SL, HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12:357-360.

[37]

Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357-359.

[38]

Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.

[39]

Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.

[40]

Du M, Wu C, Yu R, et al. A novel circular RNA, circIgfbp2, links neural plasticity and anxiety through targeting mitochondrial dysfunction and oxidative stress-induced synapse dysfunction after traumatic brain injury. Mol Psychiatry. 2022;27(11):4575-4589.

[41]

Liu J, Yang C, Yang J, Effects of early postnatal exposure to fine particulate matter on emotional and cognitive development and structural synaptic plasticity in immature and mature rats. Brain Behav. 2019;9:e01453.

[42]

Huo S, Wang Q, Shi W, et al. ATF3/SPI1/SLC31A1 signaling promotes cuproptosis induced by advanced glycosylation end products in diabetic myocardial injury. Int J Mol Sci. 2023;24:1667.

[43]

Lamtai M, Zghari O, Azirar S, et al. Melatonin modulates copper-induced anxiety-like, depression-like and memory impairments by acting on hippocampal oxidative stress in rat. Drug Chem Toxicol. 2022;45(4):1707-1715.

[44]

Xu J, He K, Zhang K, et al. Low-dose copper exposure exacerbates depression-like behavior in ApoE4 transgenic mice. Oxid Med Cell Longev. 2021;2021:6634181.

[45]

Lu Q, Zhang Y, Zhao C, Zhang H, Pu Y, Yin L. Copper induces oxidative stress and apoptosis of hippocampal neuron via pCREB/Bdnf/and Nrf2/HO-1/NQO1 pathway. J Appl Toxicol. 2022;42(4):694-705.

[46]

Zhong CC, Zhao T, Hogstrand C, Chen F, Song CC, Luo Z. Copper (Cu) induced changes of lipid metabolism through oxidative stress-mediated autophagy and Nrf2/PPARγ pathways. J Nutr Biochem. 2022;100:108883.

[47]

Fries GR, Saldana VA, Finnstein J, et al. Molecular pathways of major depressive disorder converge on the synapse. Mol Psychiatry. 2023;28(1):284-297.

[48]

Bus BA, Molendijk ML. De neurotrofe hypothese van depressie [The neurotrophic hypothesis of depression]. Tijdschr Psychiatr. 2016;58(3):215-222. Dutch.

[49]

Wang X, Song H, Du Y, et al. CircSYNDIG1 ameliorates stress-induced abnormal behaviors by suppressing miR-344-5p in mice. Brain Res Bull. 2023;195:66-77.

[50]

Wang K, Yang Y, Wang Y, Jiang Z, Fang S. CircPTK2 may be associated with depressive-like behaviors by influencing miR-182-5p. Behav Brain Res. 2024;462:114870.

[51]

Zhou Z, Ye Q, Ren H, et al. CircDYM attenuates microglial apoptosis via CEBPB/ZC3H4 axis in LPS-induced mouse model of depression. Int J Biol Macromol. 2024;254:127922.

[52]

Li X, Sun X, Xie J, Wan H. CircDYM ameliorates CUMS mice depressive-like behavior and inhibits hippocampal neurons injury via miR-497a-5p/NR3C1 axis. Brain Res. 2022;1787:147911.

[53]

Zhang Y, Du L, Bai Y, et al. CircDYM ameliorates depressive-like behavior by targeting miR-9 to regulate microglial activation via HSP90 ubiquitination. Mol Psychiatry. 2020;25:1175-1190.

[54]

Liu A, Jiang B, Song C, et al. Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR-1236/HER2 signaling pathway. MedComm (2020). 2023;4(3):e282.

[55]

Wu S, Lu J, Zhu H, et al. A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer. Cancer Lett. 2024;581:216508.

[56]

Salzman J. Circular RNA expression: its potential regulation and function. Trends Genet. 2016;32(5):309-316.

[57]

He R, Li Y, Jiao P, et al. Cuproptosis-related genes score and its hub gene GCSH: a novel predictor for cholangiocarcinomas prognosis based on RNA seq and experimental analyses. J Cancer. 2024;15:1551-1567.

[58]

Tang Y, Wang T, Li Q, Shi J, A cuproptosis score model and prognostic score model can evaluate clinical characteristics and immune microenvironment in NSCLC. Cancer Cell Int. 2024;24:68.

[59]

He T, Tang Q, Ren Q, et al. Different valence states of copper ion delivery against triple-negative breast cancer. ACS Nano. 2024. Ahead of print.

[60]

Jinshi L, Cong Y, Liang S, Dabin R, Ping Z. Cuproptosis-related genes are involved in immunodeficiency following ischemic stroke. Arch Med Sci. 2024;20:321-325.

[61]

Squitti R, Reale G, Tondolo V, et al. Imbalance of essential metals in traumatic brain injury and its possible link with disorders of consciousness. Int J Mol Sci. 2023;24:6867.

[62]

Guo J, Wang S, Wan X, et al. Mitochondria-derived methylmalonic acid aggravates ischemia-reperfusion injury by activating reactive oxygen species-dependent ferroptosis. Cell Commun Signal. 2024;22:53.

[63]

Fries GR, Saldana VA, Finnstein J, Rein T, Molecular pathways of major depressive disorder converge on the synapse. Mol Psychiatry. 2023;28:284-297.

[64]

Zhang K, Wang F, Zhai M, et al. Hyperactive neuronal autophagy depletes Bdnf and impairs adult hippocampal neurogenesis in a corticosterone-induced mouse model of depression. Theranostics. 2023;13:1059-1075.

[65]

Li X, Teng T, Yan W, et al. AKT and MAPK signaling pathways in hippocampus reveals the pathogenesis of depression in four stress-induced models. Transl Psychiatry. 2023;13:200.

[66]

Teschke R, Eickhoff A. Wilson disease: copper-mediated cuproptosis, iron-related ferroptosis, and clinical highlights, with comprehensive and critical analysis update. Int J Mol Sci. 2024;25:4753.

[67]

Xu T, Xiong M, Hong Q, et al. Hsa_circ_0007990 promotes breast cancer growth via inhibiting YBX1 protein degradation to activate E2F1 transcription. Cell Death Dis. 2024;15:153.

[68]

Liu S, Wang Y, Wang T, et al. CircPCNXL2 promotes tumor growth and metastasis by interacting with STRAP to regulate ERK signaling in intrahepatic cholangiocarcinoma. Mol Cancer. 2024;23:35.

[69]

Deen AJ, Adinolfi S, Härkönen J, et al. Oncogenic Keap1 mutations activate TRAF2-NFκB signaling to prevent apoptosis in lung cancer cells. Redox Biol. 2024;69:103031.

[70]

Bitter RM, Oh S, Deng Z, Rahman S, Hite RK, Yuan P. Structure of the Wilson disease copper transporter Atp7b. Sci Adv. 2022;8:eabl5508.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

PDF

339

Accesses

0

Citation

Detail

Sections
Recommended

/